Mobia Medical, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 5, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 12, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 12, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 2, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| Jun 2, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
| Jun 2, 2026 | BTIG | initiate | — → Buy | — | 52% |
| Jun 2, 2026 | Goldman Sachs | initiate | — → Buy | — | 54% |
No cross-platform signals in the last 90 days